CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operations
Income (loss) from continuing operations		$ (638,000,000)	$ 2,663,000,000	$ (2,421,000,000)
Income (loss) from discontinued operations, net of tax		(312,000,000)	2,482,000,000	692,000,000
Income (loss) from continuing operations		(326,000,000)	181,000,000	(3,113,000,000)
Adjustments to reconcile net income (loss) to cash flows from operations:
Depreciation and amortization		997,000,000	984,000,000	1,072,000,000
Pension settlement and curtailment (gains) losses		0	1,000,000	(12,000,000)
Net periodic pension and other postretirement costs		(28,000,000)	(29,000,000)	42,000,000
Deferred income taxes		(262,000,000)	(256,000,000)	(260,000,000)
Stock compensation		114,000,000	115,000,000	140,000,000
Long-lived asset impairments		50,000,000	0	344,000,000
Other long-lived asset impairments		44,000,000	(11,000,000)	9,000,000
Goodwill impairments		425,000,000	0	2,812,000,000
Loss on product divestiture arrangement		0	0	54,000,000
Reclassification of cumulative translation loss to earnings		0	0	65,000,000
Loss on subsidiary liquidation		0	0	21,000,000
Other		41,000,000	61,000,000	(40,000,000)
Changes in balance sheet items:
Accounts receivable, net		(35,000,000)	(38,000,000)	(48,000,000)
Inventories		(201,000,000)	(128,000,000)	(198,000,000)
Prepaid expenses and other current assets		(125,000,000)	(45,000,000)	(44,000,000)
Accounts payable		112,000,000	92,000,000	(67,000,000)
Accrued expenses and other current liabilities		44,000,000	293,000,000	(158,000,000)
Other		(31,000,000)	(13,000,000)	(91,000,000)
Cash flows from operations – continuing operations		819,000,000	1,207,000,000	528,000,000
Cash flows from operations – discontinued operations		200,000,000	519,000,000	683,000,000
Cash flows from operations		1,019,000,000	1,726,000,000	1,211,000,000
Cash flows from investing activities
Capital expenditures		(446,000,000)	(432,000,000)	(377,000,000)
Acquisitions of developed technology and investments		(14,000,000)	(4,000,000)	(258,000,000)
Proceeds from sale of marketable equity securities		34,000,000	0	0
Other investing activities, net		16,000,000	26,000,000	11,000,000
Cash flows from investing activities - continuing operations		(410,000,000)	(410,000,000)	(624,000,000)
Cash flows from investing activities - discontinued operations		(216,000,000)	3,623,000,000	(307,000,000)
Cash flows from investing activities - continuing operations		(626,000,000)	3,213,000,000	(931,000,000)
Cash flows from financing activities
Increase in short term debt		1,830,000,000	0	0
Repayments of debt		(2,657,000,000)	(2,634,000,000)	(954,000,000)
Net (decreases) increases in debt with original maturities of three months or less		296,000,000	(301,000,000)	55,000,000
Cash dividends on common stock		(590,000,000)	(586,000,000)	(573,000,000)
Proceeds from stock issued under employee benefit plans		71,000,000	95,000,000	127,000,000
Purchases of treasury stock		0	0	(32,000,000)
Other financing activities, net		(31,000,000)	(63,000,000)	(61,000,000)
Cash flows from financing activities		(1,081,000,000)	(3,489,000,000)	(1,438,000,000)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash		(96,000,000)	26,000,000	(76,000,000)
Increase (decrease) in cash, cash equivalents and restricted cash		(784,000,000)	1,476,000,000	(1,234,000,000)
Cash, cash equivalents and restricted cash at beginning of year	[1]	3,198,000,000	1,722,000,000	2,956,000,000
Cash, cash equivalents and restricted cash at end of year	[1]	2,414,000,000	3,198,000,000	1,722,000,000
Less cash and cash equivalents of discontinued operations		648,000,000	116,000,000	97,000,000
Cash, cash equivalents and restricted cash of continuing operations		$ 1,766,000,000	$ 3,082,000,000	$ 1,625,000,000

[1] The following table provides a reconciliation of cash, cash equivalents and restricted cash amounts as shown in the consolidated statement of cash flows to the amount reported in the consolidated balance sheet as of December 31, 2024, 2023, and 2022: As of December 31 (in millions)202420232022Cash and cash equivalents$1,764 $3,078 $1,621 Restricted cash included in prepaid expenses and other current assets2 4 4 Cash, cash equivalents and restricted cash$1,766 $3,082 $1,625